Preparation method of axially chiral N-benzoaryl imidazole based on heterogeneous CPA catalyst

Through the cyclization reaction of heterogeneous CPA catalyst under the condition of no molecular sieve, the problem of difficult separation and reuse of homogeneous catalysts is solved, shortening the reaction time and improving the yield of axial chiral N-benzoaryl imidazole and Enantioselectivity ensures the stability of the drug.

CN119059979APending Publication Date: 2024-12-03HARBIN INSTITUTE OF TECHNOLOGY (SHENZHEN) (INSTITUTE OF SCIENCE AND TECHNOLOGY INNOVATION HARBIN INSTITUTE OF TECHNOLOGY SHENZHEN)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411063507.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

In the prior art, homogeneous CPA catalysts are difficult to separate and reuse in organic reactions, and heterogeneous CPA catalysts are used to construct axial chiral N-benzoaryl imidazoles for a long reaction time, and molecular sieves may affect the stability of drugs. sex and bioavailability.

Method used

Using heterogeneous CPA catalysts, cyclization reactions are carried out by screening appropriate catalysts, solvents and temperatures to build axial chiral N-benzoaryl imidazoles, avoiding the use of molecular sieves, and shortening reaction time and improving yields.

Benefits of technology

Reusable use of heterogeneous CPA catalysts is achieved, the reaction time is shortened to 10h to 20h, the yield and enantioselectivity of homogeneous reactions are maintained, and the influence of molecular sieves on drug stability is avoided.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119059979A_ABST
    Figure CN119059979A_ABST
Patent Text Reader

Abstract

The invention relates to a preparation method of axially chiral N-benzoarylimidazole based on a heterogeneous CPA catalyst, which comprises the following steps: under the action of the heterogeneous CPA catalyst, mixing a diamine compound with a dicarbonyl compound and a solvent, and carrying out cyclization reaction to obtain the axially chiral N-benzoarylimidazole, by screening proper heterogeneous CPA catalyst, solvent, catalyst dosage and temperature, the yield and enantioselectivity equivalent to those of homogeneous reaction can still be obtained under the conditions of no need of molecular sieve and short reaction time.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of organic chemical synthesis, and in particular to a method for preparing axially chiral N-benzoaryl imidazole based on a heterogeneous CPA catalyst. Background Art

[0002] Organic asymmetric catalysis is an important pillar of asymmetric synthesis strategies. Chiral phosphoric acid (CPA) catalyst is a type of organic asymmetric catalyst with strong and suitable acidity. The types of asymmetric reactions catalyzed by it also include various types of asymmetric carbon-carbon bonds and carbon-hetero bonds. CPA catalysts can be divided into homogeneous CPA catalysts and heterogeneous CPA catalysts according to their distribution state in the reaction medium. Homogeneous CPA catalysts refer to catalyst systems in which the catalyst and reactants are in the same phase; heterogeneous CPA catalysts refer to catalyst systems in which the catalyst is loaded on a support and the reactants are in the liquid phase or gas phase.

[0003] Since homogeneous CPA catalysts are easily dissolved in the reaction medium, they are difficult to separate and reuse after the reaction is completed, resulting in a waste of resources. In addition, homogeneous CPA catalysts are relatively expensive.

[0004] Heterogeneous CPA catalysts have the advantages of being recyclable and easier to separate and purify, which effectively solves the problems existing in homogeneous CPA catalysis. Therefore, it is of great significance to design and synthesize efficient heterogeneous CPA catalysts and apply them in organic reactions.

[0005] Homogeneous CPA catalysts have been used in many organic reactions, but heterogeneous CPA catalysts are used in fewer reactions.

[0006] In addition, N-benzoaryl imidazole structures have received extensive attention in the past few decades due to their increasingly important roles in different fields of science and technology. For example, the N-aryl benzimidazole unit is present in a large number of bioactive molecules with a broad spectrum of pharmacological activities and is also the central core of various ligands.

[0007] However, there is no report on the use of heterogeneous CPA chiral phosphoric acid catalysts to construct axially chiral N-benzoaryl imidazoles. This is because heterogeneous catalysts usually require too long a reaction time. Therefore, molecular sieves are used to improve the selectivity, stability and reaction rate of the reaction. Due to the adsorption of molecular sieves, axially chiral N-aryl benzimidazoles may be adsorbed on the surface or in the pores of the molecular sieves. Under certain conditions, the molecular sieves may lose their structure and function, affecting the stability and effectiveness of the drug, thereby affecting the effective release and bioavailability of the drug. On the other hand, many molecular sieves are toxic to the human body or cause adverse reactions. In addition, the interaction between molecular sieves and drug molecules or other excipients may change the physicochemical properties of the drug, affecting its solubility, stability and release characteristics.

[0008] Therefore, it is of great research value to apply heterogeneous CPA catalysts in the construction reaction of axially chiral N-arylbenzimidazoles. Summary of the invention

[0009] Based on this, it is necessary to provide a method for preparing axially chiral N-benzoaryl imidazoles based on a heterogeneous CPA catalyst, and apply the heterogeneous CPA catalyst to the preparation of axially chiral N-benzoaryl imidazoles. By screening suitable heterogeneous CPA catalysts, solvents, catalyst dosages and temperatures, a yield and enantioselectivity comparable to those of a homogeneous reaction can still be obtained without the need for molecular sieves and a shorter reaction time.

[0010] The scheme adopted by the present invention is:

[0011] A method for preparing axially chiral N-benzoaryl imidazole based on a heterogeneous CPA catalyst, wherein a diamine compound is mixed with a dicarbonyl compound and a solvent under the action of a heterogeneous CPA catalyst, and a cyclization reaction occurs to obtain an axially chiral N-benzoaryl imidazole. The reaction equation is as follows:

[0012]

[0013] Wherein, R1 is -H, -CH 3 , halogen or -OMe;

[0014] R2 is phenyl or pyridyl;

[0015] R3 is -CH 3 、-COOCH 3 、CH(CH 3 ) 2 or -CH 2 CH 2 CH 3 ;

[0016] n is a positive integer from 1 to 2;

[0017] X is -CH 3 or -CH 2 CH 3 ;

[0018] Among them, the structural formula of the diamine compound is: The structural formula of dicarbonyl compounds is: or The structural formula of axially chiral N-benzoarylimidazole is:

[0019] The molar ratio of the diamine compound to the dicarbonyl compound is 1:2.

[0020] In some embodiments of the present invention, the heterogeneous CPA catalyst is a brown powder solid carrier supported hydroxy chiral phosphoric acid (Polymer-Supported CPA, PSCPA) catalyst, and the structural formula of the PSCPA catalyst is as follows:

[0021]

[0022] In the formula, PS refers to polystyrene, which usually means polystyrene resin or matrix. It is a common synthetic polymer material and is widely used as a solid phase carrier.

[0023] i-Pr refers to isopropyl, the chemical formula is -CH(CH 3 ) 2 .

[0024] The synthesis of PSCPA catalyst refers to the already reported literature 1 (Osorio Planes L, Rodríguez Escrich C, Pericàs MA. Enantioselective Continuous-Flow Production of 3-Indolylmethanamines Mediated by an Immobilized Phosphoric Acid Catalyst [J]. Chemistry-A European Journal, 2014, 20 (8): 2367-2372.) and literature 2 (Clot-Almenara L, Rodríguez-Escrich C, Osorio-Planes L, et al. Polystyrene-Supported TRIP: A Highly Recyclable Catalyst for Batch and Flow Enantioselective Allylation of Aldehydes [J]. ACS Catalysis, 2016, 6 (11): 7647-7651.), and the specific synthesis steps are as follows:

[0025]

[0026] The specific experimental steps are as follows:

[0027] (1) Synthesis of Compound 2: Compound 1 (R)-3,3′-bis(2,4,6-triisopropylphenyl)-1,1′-di-2-naphthol (2.2 mmol, 1 equiv) was added to a dry side-mouthed flask with a magnetic rod, and anhydrous dichloromethane was added under anhydrous and oxygen-free conditions to stir and dissolve. After the solid was completely dissolved, the solution was placed in a low-temperature reaction bath and cooled to -78°C. Bromine (0.56 mmol, 2.8 equiv) was added dropwise to the reaction solution at -78°C. After the addition was complete, the reaction was maintained at -78°C in a low-temperature reactor for 2.5 hours. The reaction solution was then returned to room temperature and continued to react at room temperature for 2.5 hours. After the reaction was completed, a saturated sodium sulfite solution was added to the side-mouthed flask to quench the reaction, and the organic phase was combined after extraction with dichloromethane, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain a yellow solid 2 with an isolated yield of 90%.

[0028] (2) Synthesis of compound 3: Compound 2 (1.35 mmol, 1 equiv), tetrakis(triphenylphosphine)palladium (0.13 mmol, 10 mol%), 4-vinylbenzeneboronic acid (2.7 mmol, 2 equiv), and potassium carbonate (1.38 g) were added to a dry three-necked flask with a magnetic rod, and then pumped and filled three times, and then anhydrous tetrahydrofuran and deionized water were added under anhydrous and oxygen-free conditions, and stirred to dissolve. The reaction solution was heated to 70°C and reacted for 22 hours. After the reaction was completed, the organic phase was extracted with ethyl acetate and combined, dried with anhydrous sodium sulfate, and purified by column chromatography to obtain a bright yellow solid 3 with an isolated yield of 73%.

[0029] (3) Synthesis of compound 4: Polyvinyl alcohol (0.96 μmol, 0.002 equiv) and boric acid (7.26 μmol, 7.2 equiv) were added to a dry Schlenk tube equipped with a magnet, and deoxygenated deionized water was added under anhydrous and oxygen-free conditions. The mixture was heated to 90°C and stirred until no solid was present, and then cooled to room temperature for use. Another dry Schlenk tube equipped with a magnet was added with compound 3 (0.53 mmol, 1 equiv) and azobisisobutyronitrile (AIBN) (0.19 mmol, 0.35 equiv), and anhydrous toluene was added and stirred under anhydrous and oxygen-free conditions. After complete dissolution, filtered divinylbenzene (DVB) (0.68 mmol, 1.3 equiv) and polystyrene resin (styrene) (25.5 mmol, 47.75 equiv) were added dropwise, and polyvinyl alcohol and boric acid aqueous solution cooled to room temperature were added dropwise. After the addition was complete, the mixture was heated to 80°C and stirred for 48 hours. After the reaction is complete, the reaction solution is cooled to room temperature, the polymer is filtered out with a suction filter funnel, and washed in the order of warm water, ethanol, and petroleum ether until the filtrate is nearly colorless. The obtained polymerization catalyst solid is placed in a vacuum drying oven without purification and vacuum dried overnight at 40° C. to obtain a white solid 4 (yield 99%).

[0030] (4) Synthesis of compound 5: Compound 4 (0.3 mmol, 1 equiv) was added to a dry Schlenk tube with a magnet, and anhydrous pyridine was added under anhydrous and oxygen-free conditions. After stirring evenly, anhydrous phosphorus oxychloride (1.49 mmol, 5 equiv) was slowly added dropwise using a microsyringe, and the mixture was heated to 120°C for 48 hours. After the reaction was complete, the reaction solution was cooled to room temperature, and deionized water was slowly added under a water bath, and the temperature was again raised to 100°C for overnight reaction. After the reaction was complete, the reaction solution was cooled to room temperature, and the polymer was filtered out with a suction funnel, and washed in the order of 1 M hydrochloric acid, water, ethanol, and petroleum ether. The obtained polymerization catalyst solid did not need to be purified, and was placed in a vacuum drying oven and vacuum dried overnight at 40°C to obtain a brown powder solid 5, which was the PSCPA catalyst (yield 99%).

[0031] In some embodiments of the present invention, the synthesis of the diamine compound refers to the reported literature 3 (Man N, Lou Z, Li Y, et al. Organocatalytic Atroposelective Construction of Axially Chiral N-Aryl Benzimidazoles Involving Carbon-Carbon Bond Cleavage [J]. Organic Letters, 2020, 22 (16): 6382-6387.), and the synthesis flow chart is as follows:

[0032]

[0033] Among them, compound 6 includes 6a-6b, and the structural formula is as follows:

[0034]

[0035] Compound 7 includes 7a to 7g, and the structural formula is as follows:

[0036]

[0037] The specific synthesis steps are as follows:

[0038] Add compound 6 to a flask with a magnetic rod, pump and fill it three times, add anhydrous tetrahydrofuran under anhydrous and oxygen-free conditions and stir. After complete dissolution, place the reaction solution in a low-temperature reactor and cool it to 0°C. Add sodium hydride under inert gas conditions, keep the temperature at 0°C for half an hour, then use a syringe to add compound 7 dropwise. After the addition is completed, return the reaction solution to room temperature and continue to react for 8 hours.

[0039] After the reaction was complete by TLC, saturated NH 4 The reaction mixture was quenched with Cl solution and extracted with ethyl acetate, worked up and purified by column chromatography to afford compound 8.

[0040] Compound 8 was added to a dry round-bottom flask with a magnet, and ethanol was added at room temperature. After stirring evenly, Pd / C catalyst was slowly added. The reaction solution was purged with an inert gas, and a hydrogen balloon was tied to the reaction bottle. After reacting at room temperature for 5 hours, the TLC spot plate detected that the reaction was complete, and then the solid in the reaction solution was filtered by suction. The filtrate was distilled under reduced pressure and directly purified by column chromatography to obtain the raw materials (diamine compounds) 9a-9h for the axial chirality construction reaction.

[0041] In some embodiments of the present invention, the diamine compounds include 9a-9h:

[0042]

[0043] In some embodiments of the present invention, the solvent comprises at least one of ethyl acetate and toluene.

[0044] In some embodiments of the present invention, the reaction temperature of the reaction is 40°C to 80°C.

[0045] In some embodiments of the present invention, the amount of the heterogeneous CPA catalyst used is 2 mol% to 10 mol%.

[0046] Preferably, the amount of the heterogeneous CPA catalyst used is 2 mol%.

[0047] In some embodiments of the present invention, the dicarbonyl compound comprises:

[0048]

[0049] In some embodiments of the present invention, the reaction is carried out under an inert gas atmosphere, and the inert gas is argon.

[0050] Beneficial effects of the present invention:

[0051] 1. For the first time, heterogeneous chiral phosphoric acid catalyst was used in the construction reaction of axially chiral N-benzoarylimidazole, and the heterogeneous CPA catalyst was reusable;

[0052] 2. Compared with the homogeneous reaction of constructing axially chiral N-benzoaryl imidazoles, the heterogeneous reaction can shorten the reaction time to 10h-20h without the need for molecular sieves, and still obtain the same yield and enantioselectivity as the homogeneous reaction, and can be recycled. BRIEF DESCRIPTION OF THE DRAWINGS

[0053] Figure 1 Solid-state NMR of PSCPA catalyst 13 C spectrum;

[0054] Figure 2 Solid-state NMR of PSCPA catalyst 31 P spectrum;

[0055] Figure 3 is the XPS spectrum of PSCPA catalyst;

[0056] Figure 4 TEM image of PSCPA catalyst. DETAILED DESCRIPTION

[0057] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.

[0058] In the examples, the test methods used are conventional methods unless otherwise specified, and the materials, reagents, etc. used are all commercially available unless otherwise specified.

[0059] 1. The preparation steps of the PSCPA catalyst used in all embodiments of the present invention are as follows:

[0060] (1) Synthesis of Compound 2: Compound 1 (R)-3,3′-bis(2,4,6-triisopropylphenyl)-1,1′-di-2-naphthol (2.2 mmol, 1 equiv) was added to a dry side-mouthed flask with a magnetic rod, and anhydrous dichloromethane was added under anhydrous and oxygen-free conditions to stir and dissolve. After the solid was completely dissolved, the solution was placed in a low-temperature reaction bath and cooled to -78°C. Bromine (0.56 mmol, 2.8 equiv) was added dropwise to the reaction solution at -78°C. After the addition was complete, the reaction was maintained at -78°C in a low-temperature reactor for 2.5 hours. The reaction solution was then returned to room temperature and continued to react at room temperature for 2.5 hours. After the reaction was completed, a saturated sodium sulfite solution was added to the side-mouthed flask to quench the reaction, and the organic phase was combined after extraction with dichloromethane, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain a yellow solid 2 with an isolated yield of 90%.

[0061] (2) Synthesis of compound 3: Compound 2 (1.35 mmol, 1 equiv), tetrakis(triphenylphosphine)palladium (0.13 mmol, 10 mol%), 4-vinylbenzeneboronic acid (2.7 mmol, 2 equiv), and potassium carbonate (1.38 g) were added to a dry three-necked flask with a magnetic rod, and then pumped and filled three times, and then anhydrous tetrahydrofuran and deionized water were added under anhydrous and oxygen-free conditions, and stirred to dissolve. The reaction solution was heated to 70°C and reacted for 22 hours. After the reaction was completed, the organic phase was extracted with ethyl acetate and combined, dried with anhydrous sodium sulfate, and purified by column chromatography to obtain a bright yellow solid 3 with an isolated yield of 73%.

[0062] (3) Synthesis of compound 4: Polyvinyl alcohol (0.96 μmol, 0.002 equiv) and boric acid (7.26 μmol, 7.2 equiv) were added to a dry Schlenk tube equipped with a magnet, and deoxygenated deionized water was added under anhydrous and oxygen-free conditions. The mixture was heated to 90°C and stirred until no solid was present, and then cooled to room temperature for use. Another dry Schlenk tube equipped with a magnet was added with compound 3 (0.53 mmol, 1 equiv) and azobisisobutyronitrile (AIBN) (0.19 mmol, 0.35 equiv), and anhydrous toluene was added and stirred under anhydrous and oxygen-free conditions. After complete dissolution, filtered divinylbenzene (DVB) (0.68 mmol, 1.3 equiv) and polystyrene resin (styrene) (25.5 mmol, 47.75 equiv) were added dropwise, and polyvinyl alcohol and boric acid aqueous solution cooled to room temperature were added dropwise. After the addition was complete, the mixture was heated to 80°C and stirred for 48 hours. After the reaction is complete, the reaction solution is cooled to room temperature, the polymer is filtered out with a suction filter funnel, and washed in the order of warm water, ethanol, and petroleum ether until the filtrate is nearly colorless. The obtained polymerization catalyst solid is placed in a vacuum drying oven without purification and vacuum dried overnight at 40° C. to obtain a white solid 4 (yield 99%).

[0063] (4) Synthesis of compound 5: Compound 4 (0.3 mmol, 1 equiv) was added to a dry Schlenk tube with a magnet, and anhydrous pyridine was added under anhydrous and oxygen-free conditions. After stirring evenly, anhydrous phosphorus oxychloride (1.49 mmol, 5 equiv) was slowly added dropwise using a microsyringe, and the mixture was heated to 120°C for 48 hours. After the reaction was complete, the reaction solution was cooled to room temperature, and deionized water was slowly added under a water bath, and the temperature was again raised to 100°C for overnight reaction. After the reaction was complete, the reaction solution was cooled to room temperature, and the polymer was filtered out with a suction funnel, and washed in the order of 1 M hydrochloric acid, water, ethanol, and petroleum ether. The obtained polymerization catalyst solid did not need to be purified, and was placed in a vacuum drying oven and vacuum dried overnight at 40°C to obtain a brown powder solid 5, which was the PSCPA catalyst (yield 99%).

[0064] Solid-state NMR of the prepared PSCPA catalyst 13 C spectrum Figure 1 As shown, the solid-state NMR of PSCPA catalyst 31 P spectrum Figure 2 The XPS spectrum of PSCPA catalyst is shown in Figure 3 The TEM image of PSCPA catalyst is shown in Figure 4 shown.

[0065] The specific synthesis steps are as follows:

[0066]

[0067] 2. The synthesis steps of all diamine compounds used in the embodiments of the present invention are as follows:

[0068] Add compound 6 to a flask with a magnetic rod, pump and fill it three times, add anhydrous tetrahydrofuran under anhydrous and oxygen-free conditions and stir. After complete dissolution, place the reaction solution in a low-temperature reactor and cool it to 0°C. Add sodium hydride under inert gas conditions, keep the temperature at 0°C for half an hour, then use a syringe to add compound 7 dropwise. After the addition is completed, return the reaction solution to room temperature and continue to react for 8 hours.

[0069] After the reaction was complete by TLC, saturated NH 4 The reaction mixture was quenched with Cl solution and extracted with ethyl acetate, worked up and purified by column chromatography to afford compound 8.

[0070] Compound 8 was added to a dry round-bottom flask with a magnet, and ethanol was added at room temperature. After stirring evenly, Pd / C catalyst was slowly added. The reaction solution was purged with an inert gas, and a hydrogen balloon was tied to the reaction bottle. After reacting at room temperature for 5 hours, the reaction was detected to be complete by TLC spot plate, and the solid in the reaction solution was filtered by suction. The filtrate was distilled under reduced pressure and then directly purified by column chromatography to obtain the raw material (diamine compound) 9 for the axial chirality construction reaction.

[0071] The synthesis flow chart is as follows:

[0072]

[0073] In the description of the present invention, it should be noted that, if the specific conditions are not specified in the examples, the conventional conditions are followed. Other reagents or instruments used without specifying the manufacturer are conventional products that can be purchased commercially.

[0074] Example 1

[0075] Explore the differences in catalytic performance of SSCPA catalyst, PSCPA catalyst, TRIP catalyst and sty-CPA catalyst in the synthesis of axially chiral N-benzoarylimidazole.

[0076] Among them, the diamine compound in the axial chiral N-benzoaryl imidazole synthesis reaction of this embodiment is Dicarbonyl compounds are SSCPA PSCPA Catalyst TRIP catalyst is Sty-CPA catalyst is

[0077] The steps for the synthesis of axially chiral N-benzoarylimidazoles are:

[0078] Add 0.1 mmol of diamine compound to a dry Schlenk tube with a magnet, add 1.5 ml of anhydrous toluene under anhydrous and oxygen-free conditions and stir. After complete dissolution, slowly add 0.2 mmol of dicarbonyl compound dropwise using a syringe under inert gas (argon) conditions. After complete stirring, add a certain amount of catalyst and molecular sieve at room temperature, raise the temperature to the reaction temperature, and react for a period of time.

[0079] After the reaction was complete as detected by TLC spot plate, the reaction solution was cooled to room temperature, the obtained mixture was filtered using a suction funnel to remove the catalyst, and then directly subjected to column chromatography separation and purification to obtain axial chiral N-benzoaryl imidazole.

[0080] The reactants in this embodiment are as follows: diamine compound: Dicarbonyl compounds:

[0081] The reaction conditions and results are shown in Table 1.

[0082] Table 1 The results of the investigation of the catalyst on the synthesis reaction of axial chiral N-benzoaryl imidazole

[0083]

[0084] As shown in Table 1, the TRIP catalyst and the sty-CPA catalyst are homogeneous catalysts. Under the same conditions, the yields of the TRIP catalyst and the sty-CPA catalyst are 88% and 90%, and the enantioselectivities are 92 and 90%, respectively, which indicates that the styrene group at the 6,6'-position of the homogeneous catalyst does not affect the catalytic activity of the catalyst.

[0085] The SSCPA catalyst and the PSCPA catalyst are self-supported heterogeneous catalysts. The yield of the SSCPA catalyst is 90%, which achieves the same effect as the homogeneous phase, but the enantioselectivity is only 20%. This may be due to the fact that the catalyst is arranged too closely during the self-support using covalent bonds, resulting in the encapsulation of the chiral sites. The change in the chiral structure leads to a decrease in enantioselectivity. When the carrier-supported heterogeneous PSCPA catalyst is used for the axial chirality construction reaction under the same conditions, the yield of the target product reaches 96%, and the enantioselectivity reaches 96%, both of which are higher than the homogeneous reaction.

[0086] Since homogeneous CPA catalysts are easily dissolved in the reaction medium, they are difficult to separate and reuse after the reaction is completed, resulting in a waste of resources. The present invention uses a carrier-supported heterogeneous catalyst PSCPA as a catalyst for the reaction, which can be recycled and reused, and is easier to separate and purify. It effectively solves the problems existing in homogeneous CPA catalysis, and can still obtain a yield and enantioselectivity comparable to that of a homogeneous reaction under the same conditions.

[0087] Example 2

[0088] To investigate the effect of solvent on the synthesis reaction of axially chiral N-benzoarylimidazoles.

[0089] The steps for the synthesis of axially chiral N-benzoarylimidazoles are:

[0090] Add 0.1 mmol of diamine compound to a dry Schlenk tube equipped with a magnet, add 1.5 ml of solvent under anhydrous and oxygen-free conditions and stir. After complete dissolution, slowly add 0.2 mmol of dicarbonyl compound dropwise using a syringe under inert gas (argon) conditions. After complete stirring, add 10 mol% of heterogeneous PSCPA catalyst at room temperature, raise the temperature to 60°C, and react for 10 hours.

[0091] After the reaction was complete as detected by TLC spot plate, the reaction solution was cooled to room temperature, the obtained mixture was filtered using a suction funnel to remove the catalyst, and then directly subjected to column chromatography separation and purification to obtain axial chiral N-benzoaryl imidazole.

[0092] The reactants in this embodiment are as follows: diamine compound: Dicarbonyl compounds:

[0093] The use of solvents and their yields and ee are shown in Table 2 , and the results are shown in Table 2 .

[0094] Table 2 Effect of solvent on the synthesis reaction of axial chiral N-benzoaryl imidazole

[0095]

[0096] As shown in Table 2, under the same conditions, when the protic solvent methanol is used as the solvent, the yield of the target product is only 12%, and the enantioselectivity is 20%; when the non-protic solvent acetonitrile, ethylene glycol dimethyl ether, tetrahydrofuran, 1,4-dioxane is used as the solvent, the yield and enantioselectivity are also low; when the alkane solvents dichloroethane, dichloromethane, chloroform, and n-hexane are used as the reaction solvent, although the enantioselectivity is improved, the yield remains at a low level; and the lipid solvent ethyl acetate slightly improves the reaction effect to a yield of 80% and an enantioselectivity of 93%; when toluene is used as the solvent, the best effect is achieved, with a yield of 96% and an enantioselectivity of 96%.

[0097] Example 3

[0098] Investigate the effects of reaction conditions (reaction temperature, catalyst dosage, reaction time, molecular sieve) on the synthesis of axially chiral N-benzoarylimidazoles.

[0099] The steps for the synthesis of axially chiral N-benzoarylimidazoles are:

[0100] Add 0.1 mmol of diamine compound to a dry Schlenk tube with a magnet, add 1.5 ml of solvent (toluene) under anhydrous and oxygen-free conditions and stir. After complete dissolution, slowly add 0.2 mmol of dicarbonyl compound dropwise using a syringe under inert gas (argon) conditions. After complete stirring, add a certain amount of catalyst (or molecular sieve at the same time) at room temperature, raise the temperature to a certain temperature, and react for a certain period of time.

[0101] After the reaction was complete as detected by TLC spot plate, the reaction solution was cooled to room temperature, the obtained mixture was filtered using a suction funnel to remove the catalyst, and then directly subjected to column chromatography separation and purification to obtain axial chiral N-benzoaryl imidazole.

[0102] The reactants in this embodiment are as follows: diamine compound: Dicarbonyl compounds:

[0103] The reaction conditions and results are shown in Table 3.

[0104] Table 3 Effect of reaction conditions on the synthesis of axially chiral N-benzoaryl imidazoles

[0105]

[0106]

[0107] Note: In the table Molecular sieve( Molecular sieve) is a synthetic zeolite with a pore size of That is 0.3 nanometers. The pore size of this molecular sieve enables it to selectively adsorb particles with a diameter smaller than molecules while repelling larger molecules.

[0108] From 3, we can see the effect of reaction temperature on the yield and enantioselectivity of the target product of the reaction: when the reaction is carried out at room temperature (sequence number 1), the yield of the target product is 36% and the enantioselectivity is 73%, while when the temperature is raised to 40°C (sequence number 2) for the reaction, the yield of the target product is greatly increased to 80%, and the enantioselectivity also reaches 95%, indicating the importance of temperature for the axial chiral construction reaction. So we tried to raise the temperature again, and at 60°C (sequence number 3), the yield of the target product reached 96%, and the enantioselectivity remained stable at 96%. After continuing to raise the temperature, neither the yield nor the enantioselectivity will increase. Therefore, it is determined that 40°C to 80°C is the optimal reaction temperature for the axial chiral construction reaction, preferably 60°C.

[0109] The effect of catalyst dosage on the yield and enantioselectivity of the target product of the reaction: When the equivalent of homogeneous catalyst TRIP (sequence number 5) and carrier-supported heterogeneous catalyst PSCPA (sequence number 6) is reduced to 5 mol%, the yield of the target product of the homogeneous reaction is 87%, and the enantioselectivity is 85%, while the yield of the target product of the heterogeneous reaction is 96%, and the enantioselectivity is 96%. When the catalyst equivalent is reduced to 2 mol% (sequence number 7), the yield of the target product is 96%, and the enantioselectivity is 96%. When the catalyst dosage is further reduced to 1 mol% (sequence number 8), 0.5 mol% (sequence number 10), and 0.2 mol% (sequence number 12), the yield of the target product is 62%, 57%, and 45%, respectively, and the enantioselectivity is 95%. After the temperature is increased and the reaction time is extended, the lower yields (sequence numbers 9, 11, and 13) do not increase significantly. Considering the catalytic effect and atom economy, the catalyst dosage of the axial chirality construction reaction is determined to be 2 mol% to 10 mol%, preferably 2 mol%.

[0110] Effect of molecular sieves on the yield and enantioselectivity of the target product of the reaction: It was observed that the self-supported heterogeneous catalyst PSCPA was in powder form, so an attempt was made to carry out the reaction without the addition of molecular sieves (Sequence No. 15), and the yield of the target product was 96%, and the enantioselectivity was 96%. The yield of the target product obtained by catalyzing the reaction by homogeneous TRIP (Sequence No. 14) without molecular sieves was 78%, and the enantioselectivity was 82%. Therefore, there is no need to add molecular sieves when using PSCPA to catalyze the reaction.

[0111] Effect of reaction time on the yield and enantioselectivity of the target product of the reaction: Sequence number 16 in Table 3 is the result of 5 hours of reaction, the yield of the target product is 68%, and the enantioselectivity is 96%. The result of 10 hours of reaction (sequence number 17): the yield of the target product is 96%, and the enantioselectivity is 96%. Sequence number 18 in the table is the result of 15 hours of reaction, the yield of the target product is 96%, and the enantioselectivity is 96%. It shows that after 5 hours of reaction, there is still raw material left. During the continued reaction, the yield of the target product will also increase accordingly. After 10 hours, the raw material is basically reacted. Extending the time will not affect the yield and enantioselectivity of the target product. Therefore, the reaction time of the axial chiral N-benzoaryl imidazole construction reaction is determined to be 10h to 20h, preferably 10h.

[0112] Example 4

[0113] Verify the recovery and reusability of PSCPA catalyst.

[0114] The steps for the synthesis of axially chiral N-benzoarylimidazoles are:

[0115] Add 0.1 mmol of diamine compound to a dry Schlenk tube equipped with a magnet, add 1.5 ml of solvent (toluene) under anhydrous and oxygen-free conditions and stir. After complete dissolution, slowly add 0.2 mmol of dicarbonyl compound dropwise using a syringe under inert gas (argon) conditions. After complete stirring, add 2 mol% of heterogeneous PSCPA catalyst at room temperature, raise the temperature to 60°C, and react for 10 hours.

[0116] After the reaction was complete as detected by TLC spot plate, the reaction solution was cooled to room temperature, the obtained mixture was filtered using a suction funnel to remove the catalyst, and then directly subjected to column chromatography separation and purification to obtain axial chiral N-benzoaryl imidazole.

[0117] The reactants in this embodiment are as follows: diamine compound: Dicarbonyl compounds:

[0118] The PSCPA catalyst is recycled and reused in the following steps:

[0119] When the catalytic reaction is completed, the catalyst is removed through the filter funnel.

[0120] Separate, use dichloromethane to wash away the residual toluene solvent as well as the reactants and products, and observe the fluorescence signal of the filtrate under a 254nm ultraviolet lamp to ensure that all the chemicals in the previous cycle are washed clean. The collected solid catalyst is ground, placed in a vacuum drying oven, and vacuum dried at 60°C for 24 hours before being used for the next catalytic reaction. The crude product is separated and purified by column chromatography to obtain the target axial chiral product. The first yield was 96% and the enantioselectivity was 96%. After 12 consecutive catalytic reactions of the axial chirality, the yield was 95% and the enantioselectivity was 95%. Compared with the first yield and enantioselectivity, there was no obvious loss, which indicates that the catalytic activity and enantioselectivity of PSCPA are maintained during the cycle.

[0121] Example 5

[0122] The PSCPA catalyst was used to verify the reaction of different reaction substrates (diamine compounds and dicarbonyl compounds).

[0123] The steps for the synthesis of axially chiral N-benzoarylimidazoles are:

[0124] Add 0.1 mmol of diamine compound to a dry Schlenk tube equipped with a magnet, add 1.5 ml of solvent (toluene) under anhydrous and oxygen-free conditions and stir. After complete dissolution, slowly add 0.2 mmol of dicarbonyl compound dropwise using a syringe under inert gas (argon) conditions. After complete stirring, add 2 mol% of heterogeneous PSCPA catalyst at room temperature, raise the temperature to 60°C, and react for 10 hours.

[0125] After the reaction was complete as detected by TLC spot plate, the reaction solution was cooled to room temperature, the obtained mixture was filtered using a suction funnel to remove the catalyst, and then directly subjected to column chromatography separation and purification to obtain axial chiral N-benzoaryl imidazole. The results of ee and yield are shown in Table 4 below for different reaction substrates and products.

[0126] Table 4 ee and yield of different reaction substrates and products

[0127]

[0128]

[0129]

[0130] As shown in Table 4 above, firstly, by changing the substituents on the benzene ring in benzimidazole, excellent yields and enantioselectivities were obtained. When the naphthalene ring was changed to quinoline, it did not affect the reaction results. When acetylacetone was replaced with a chain ketone compound, the yield of the substrate without substituents on the benzene ring was very low, but the enantioselectivity was only slightly reduced. When substituents appeared on the benzene ring, excellent yields and enantioselectivities were obtained.

[0131] In addition, cyclic substrates were tried as dicarbonyl compounds, and excellent yields and enantioselectivities were obtained in both five-membered and six-membered rings, but only 20% yield was obtained for the seven-membered ring, and the enantioselectivity was still good.

[0132] The axially chiral N-benzoaryl imidazole prepared in Example 5 was characterized, and the characterization results are as follows:

[0133] 1.

[0134] (S)-2-Methyl-1-(naphthalene-1-yl)-1H-benzo[d]imidazole 4aa(91%yield,96%ee)Brown oil.Optical:[α] 25 D = -172.432° (c = 0.84, CHCl 3 )

[0135] 1 H NMR (400 MHz, CDCl 3 )δ7.92(d,J=8.4 Hz,1H),7.87(d,J=8.0 Hz,1H),7.72(d,J=8.0Hz,1H),7.50(t,J=7.8 Hz,1H),7.43(t,J=7.6 Hz,1H),7.36(d,J=7.2 Hz, 1H), 7.4 (t, J = 7.8 Hz 1H), 7.15 (t, J = 7.8 Hz, 1H), 7.05 (d, J = 8.8 Hz, 1H), 6.99 (t, J = 7.6 Hz, 1H), 6.72 (d, J = 7.6 Hz, 1H), 2.26 (s, 3H).

[0136] 13 C NMR (100 MHz, CDCl 3 )δ152.7,142.8,137.5,134.6,132.4,130.4,129.9,128.6,127.8,127.1,126.2,125.7,122.7,122.5,122.4,119.1,110.3,14.2.

[0137] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=11.4 min,t R (major)=13.2 min),ee=96%.

[0138] 2.

[0139] (S)-2,5-Dimethyl-1-(naphthalene-1-yl)-1H-benzo[d]imidazole 4ba(96%yield,95%ee)Brown oil.

[0140] Optical:[α] 25 D=-32.102°(c=0.25,CHCl 3 )

[0141] 1 H NMR(400 MHz,CDCl 3 )δ8.08(d,J=8.3 Hz,1H),8.03(d,J=8.3 Hz,1H),7.70-7.63(m,2H),7.60(t,J=7.5 Hz,1H),7.52(d,J=7.2 Hz,1H),7.45(t,J=7.7 Hz,1H),7.22(d,J=8.5Hz,1H),6.99(d,J=8.2 Hz,1H),6.77(d,J=8.2 Hz,1H),2.53(s,3H),2.40(s,3H).

[0142] 13 C NMR(100 MHz,CDCl 3 )δ152.6,142.9,135.6,134.6,132.6,132.1,130.4,129.9,128.6,127.7,127.1,126.1,125.7,124.0,122.6,118.9,109.8,21.6,14.1.

[0143] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=13.1 min,tR (major)=16.0 min),ee=95%.

[0144] 3.

[0145] (S)-5-Fluoro-2-methyl-1-(naphthaleN-1-yl)-1H-benzo[d]imidazole 4ca(95%yield,95%ee)White solid.

[0146] Optical:[α] 25 D=-3.600°(c=0.10,CHCl 3 )

[0147] 1 H NMR(400 MHz,CDCl 3 )δ8.07(d,J=8.3 Hz,1H),8.02(d,J=8.3 Hz,1H),7.68-7.62(m,1H),7.58(t,J=7.6 Hz,1H),7.53-7.42(m,3H),7.15(d,J=8.5 Hz,1H),6.92-6.85(m,1H),6.76(dd,J=8.8,4.6 Hz,1H),2.37(s,3H).

[0148] 13 C NMR(100 MHz,CDCl 3 )δ159.6(d, 1 J C-F =235 Hz),154.3,143.2(d, 3 J C-F =13Hz),134.6,133.9,132.1,130.3,130.2,128.7,127.9,127.2,126.2,125.7,122.3,110.9(d, 2 J C-F =25 Hz),110.5(d, 3 J C-F =13 Hz),105.1(d, 2 J C-F =24 Hz),14.2.

[0149] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(tR (minor)=10.4 min,t R (major)=12.5 min),ee=95%.

[0150] 4.

[0151] (S)-5-Chloro-2-methyl-1-(naphthalene-1-yl)-1H-benzo[d]imidazole 4da(95%yield,97%ee)White solid.

[0152] Optical:[α] 25 D=-4.400°(c=0.11,CHCl 3 )

[0153] 1 H NMR(400 MHz,CDCl 3 )δ8.07(d,J=8.3 Hz,1H),8.02(d,J=8.3 Hz,1H),7.79(s,1H),7.65(t,J=7.8 Hz,1H),7.58(t,J=7.5 Hz,1H),7.50(d,J=7.2 Hz,1H),7.44(t,J=7.6 Hz,1H),7.11(t,J=8.9 Hz,2H),6.76(d,J=8.5 Hz,1H),2.37(s,3H).

[0154] 13 C NMR(100 MHz,CDCl 3 )δ154.1,143.5,136.1,134.6,131.9,130.2,130.2,128.7,128.0,127.9,127.2,126.1,125.7,123.1,122.2,118.9,111.0,14.2.

[0155] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=12.6 min,t R (major)=15.9 min),ee=97%.

[0156] 5.

[0157] (S)-5-Bromo-2-methyl-1-(naphthaleN-1-yl)-1H-benzo[d]imidazole 4ea(76%yield,80%ee)White solid.

[0158] Optical:[α] 25 D=-5.280°(c=0.12,CHCl 3 )

[0159] 1 H NMR(400 MHz,CDCl 3 )δ8.11(d,J=8.3 Hz,1H),8.05(d,J=8.3 Hz,1H),7.98(d,J=1.7Hz,1H),7.71-7.66(m,1H),7.62(t,J=7.6 Hz,1H),7.55-7.45(m,2H),7.27(d,J=8.5 Hz,1H),7.15(d,J=8.4 Hz,1H),6.76(d,J=8.5 Hz,1H),2.40(s,3H).

[0160] 13 C NMR(100 MHz,CDCl 3 )δ153.9,144.1,136.4,134.6,131.9,130.3,130.2,128.7,128.0,127.2,126.1,125.7,122.2,122.0,115.4,111.5,14.2.

[0161] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=14.3 min,t R (major)=18.3 min),ee=80%.

[0162] 6.

[0163] (S)-7-Chloro-2-methyl-1-(naphthalene-1-yl)-1H-benzo[d]imidazole 4fa(85%yield,89%ee)Brown oil.

[0164] Optical:[α] 25D=-47.661°(c=0.57,CHCl 3 )

[0165] 1 H NMR(400 MHz,CDCl 3 )δ8.06(d,J=8.2 Hz,1H),7.99(d,J=8.2 Hz,1H),7.74(d,J=7.9Hz,1H),7.64-7.59(m,1H),7.55(q,J=6.9 Hz,2H),7.44(t,J=7.3 Hz,1H),7.21(t,J=7.9 Hz,1H),7.11(d,J=7.7 Hz,2H),2.30(s,3H).

[0166] 13 C NMR(100 MHz,CDCl 3 )δ154.2,144.6,134.0,133.0,131.7,130.1,128.5,127.9,127.0,125.2,124.0,123.0,122.2,118.0,116.4,14.1.

[0167] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=10.3 min,t R (major)=11.0 min),ee=89%.

[0168] 7.

[0169] (S)-5-(2-Methyl-1H-benzo[d]imidazole-1-yl)quinolone 4ha(80%yield,91%ee)Brown oil.Optical:[α] 25 D=-6.760°(c=0.13,CHCl 3 )

[0170] 1 H NMR(400 MHz,CDCl 3)δ9.02(d,J=2.7 Hz,1H),8.35(d,J=8.6 Hz,1H),7.94-7.88(m,1H),7.83(d,J=8.1 Hz,1H),7.61(d,J=7.3 Hz,1H),7.55(d,J=8.5 Hz,1H),7.38(dd,J=8.5,4.2 Hz,1H),7.30(t,J=7.6 Hz,1H),7.16(t,J=7.6 Hz,1H),6.83(d,J=8.0 Hz,1H),2.39(s,3H).

[0171] 13 C NMR(100 MHz,CDCl 3 )δ152.4,151.5,149.0,142.7,137.4,132.3,131.5,131.1,129.2,126.8,125.8,123.0,122.7,122.6,119.3,110.0,14.2.

[0172] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=19.5 min,t R (major)=21.3 min),ee=91%.

[0173] 8.

[0174] (S)-Methyl-2-(1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)acetate4ad(30%yield,84%ee)Brown oil.

[0175] Optical:[α] 25 D=-5.200°(c=0.10,CHCl 3 )

[0176] 1 H NMR(400 MHz,CDCl 3)δ8.06(d,J=8.3 Hz,1H),7.99(d,J=8.3 Hz,1H),7.89(d,J=8.1Hz,1H),7.63(t,J=7.7 Hz,1H),7.56(t,J=7.0 Hz,2H),7.41(t,J=7.3 Hz,1H),7.31(t,J=7.2 Hz,1H),7.17(dt,J=7.2,2.9 Hz,2H),6.86(d,J=8.1 Hz,1H),3.90(d,J=16.5 Hz,1H),3.70(d,J=16.5 Hz,1H),3.49(s,3H).

[0177] 13 C NMR(100 MHz,CDCl 3 )δ168.5,148.7,142.6,137.4,134.5,131.6,130.4,130.3,128.6,127.8,127.2,126.7,125.7,123.4,122.8,122.5,119.9,110.7,52.4,34.3.

[0178] 9.

[0179] (S)-Methyl-2-(5-methyl-1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)acetate4bd(96%yield,88%ee)Brown oil.

[0180] Optical:[α] 25 D=-5.200°(c=0.10,CHCl 3 )

[0181] 1 H NMR(400 MHz,CDCl 3 )δ8.05(d,J=8.2 Hz,1H),7.99(d,J=8.2 Hz,1H),7.63(dd,J=15.5,7.7 Hz,2H),7.59-7.52(m,2H),7.41(t,J=7.7 Hz,1H),7.18(d,J=8.5 Hz,1H),7.01(d,J=8.3 Hz,1H),6.76(d,J=8.2 Hz,1H),3.88(d,J=16.5 Hz,1H),3.67(d,J=16.5 Hz,1H),3.49(s,3H),2.50(s,3H).

[0182] 13 C NMR(100 MHz,CDCl 3 )δ168.6,148.5,135.6,134.5,132.5,131.8,130.3,130.2,128.6,127.7,127.1,126.6,125.6,124.8,122.6,119.6,110.2,52.4,34.3,21.7.

[0183] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=25.9 min,t R (major)=34.7 min),ee=88%.

[0184] 10.

[0185] (S)-Methyl-2-(5-fluoro-1-(naphthaleN-1-yl)-1H-benzo[d]imidazol-2-yl)acetate4cd(95%yield,94%ee)Brown oil.

[0186] Optical:[α] 25 D=-6.240°(c=0.12,CHCl 3 )

[0187] 1 H NMR(400 MHz,CDCl 3 )δ8.08(d,J=8.2 Hz,1H),8.01(d,J=8.2 Hz,1H),7.67-7.61(m,1H),7.61-7.51(m,3H),7.45(t,J=8.2 Hz,1H),7.14(d,J=8.5 Hz,1H),6.98-6.90(m,1H),6.79(dd,J=8.8,4.6 Hz,1H),3.88(d,J=16.6 Hz,1H),3.67(d,J=16.6 Hz,1H),3.51(s,3H). 13 C NMR(100 MHz,CDCl 3 )δ168.4,158.5(d, 1 J C-F =235 Hz),150.1,143.0(d,3 J C-F =13 Hz),134.5,133.9,131.3,130.6,130.2,128.7,127.9,127.3,126.7,125.6,122.3,111.8(d, 2 J C-F =25Hz),111.1(d, 3 J C-F =10 Hz),105.7(d, 2 J C-F =24 Hz),52.5,34.3.

[0188] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=18.9 min,t R (major)=23.8 min),ee=94%.

[0189] 11.

[0190] (S)-Methyl-2-(5-chloro-1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)acetate4dd(90%yield,93%ee)Brown oil.

[0191] Optical:[α] 25 D=-6.200°(c=0.13,CHCl 3 )

[0192] 1 H NMR(400 MHz,CDCl 3 )δ8.08(d,J=8.3 Hz,1H),8.01(d,J=8.2 Hz,1H),7.86(s,1H),7.60(m,3H),7.44(t,J=7.6 Hz,1H),7.13(t,J=8.5 Hz,2H),6.78(d,J=8.6 Hz,1H),3.88(d,J=16.6 Hz,1H),3.68(d,J=16.6 Hz,1H),3.50(s,3H).

[0193] 13 C NMR(100 MHz,CDCl 3)δ168.3,149.9,143.3,135.9,134.5,131.1,130.6,130.1,128.7,128.5,127.9,127.3,126.7,125.6,123.9,122.3,119.7,111.5,52.5,34.3.

[0194] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=24.8 min,t R (major)=31.6 min),ee=93%.

[0195] 12.

[0196] (S)-Methyl-2-(6-methoxy-1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)acetate4gd(76%yield,84%ee)Brown oil.

[0197] Optical:[α] 25 D=-5.200°(c=0.11,CHCl 3 )

[0198] 1 H NMR(400 MHz,CDCl 3 )δ8.07(d,J=8.2 Hz,1H),8.00(d,J=8.3 Hz,1H),7.75(d,J=8.8Hz,1H),7.66-7.61(m,1H),7.57(t,J=7.7 Hz,2H),7.43(t,J=7.7 Hz,1H),7.20(d,J=8.5 Hz,1H),6.95(d,J=11.2 Hz,1H),6.31(s,1H),3.85(d,J=16.6 Hz,1H),3.67-3.61(m,4H),3.48(s,3H).

[0199] 13 C NMR(100 MHz,CDCl 3)δ168.7,157.2,147.7,138.0,137.0,134.6,131.7,130.3,130.2,128.6,127.8,127.2,126.7,125.7,122.6,120.4,112.2,94.0,55.8,52.3,34.3.

[0200] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=80:20;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=17.4 min,t R (major)=21.9 min),ee=84%.

[0201] 13.

[0202] (S)-2-Isopropyl-1-(naphthalene-1-yl)-1H-benzo[d]imidazole4ac(40%yield,84%ee)White solid.Optical:[α] 25 D=-4.200°(c=0.10,CHCl 3 )

[0203] 1 H NMR(400 MHz,CDCl 3 )δ8.06(d,J=8.3 Hz,1H),8.00(d,J=8.2 Hz,1H),7.88(d,J=8.1Hz,1H),7.68-7.61(m,1H),7.60-7.49(m,2H),7.41(t,J=7.7 Hz,1H),7.29(d,J=7.2 Hz,1H),7.17-7.08(m,2H),6.80(d,J=8.0 Hz,1H),2.85(m,1H),1.35(d,J=6.9Hz,3H),1.26(d,J=6.8 Hz,3H).

[0204] 13 C NMR(100 MHz,CDCl 3 )δ161.2,142.6,137.2,134.6,132.4,130.7,129.9,128.6,127.8,127.1,126.5,125.7,122.7,122.5,122.4,119.3,110.3,26.9,22.3,21.6.

[0205] HPLC analysis:Daicel Chiralpak ID;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254 nm;25℃;(t R (minor)=8.2 min,t R (major)=10.4 min),ee=84%.

[0206] 14.

[0207] (S)-5-fluoro-2-isopropyl-1-(naphthalene-1-yl)-1H-benzo[d]imidazole4cc(82%yield,80%ee)White solid.

[0208] Optical:[α] 25 D=-4.400°(c=0.11,CHCl 3 )

[0209] 1 H NMR(400 MHz,CDCl 3 )δ8.07(d,J=8.3 Hz,1H),8.01(d,J=8.2 Hz,1H),7.65(t,J=7.8Hz,1H),7.61-7.48(m,3H),7.43(t,J=7.6 Hz,1H),7.11(d,J=8.5 Hz,1H),6.91-6.82(m,1H),6.70(dd,J=8.7,4.7 Hz,1H),2.82(m,1H),1.35(d,J=6.9 Hz,3H),1.25(d,J=6.9 Hz,3H). 13 C NMR(100 MHz,CDCl 3 )δ162.7,159.6(d, 1 J C-F =235 Hz),143.0(d, 3 J C-F =13 Hz),134.6,133.7,132.1,130.6,130.2,128.6,127.9,127.2,126.5,125.7,122.3,110.9,110.6(d, 3 J C-F =25Hz),105.2(d, 2 J C-F=24 Hz),27.1,22.2,21.5.

[0210] HRMS(ESI):m / z calcd for C 20 H 17 FN 2 [M+H]+:305.1449;found:305.1452HPLCanalysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=5.8 min,t R (major)=6.6 min),ee=80%.

[0211] 15.

[0212] (S)-5-Chloro-2-isopropyl-1-(naphthalene-1-yl)-1H-benzo[d]imidazole4dc(60%yield,91%ee)White solid.

[0213] Optical:[α] 25 D=-5.040°(c=0.12,CHCl 3 )

[0214] 1 H NMR(400 MHz,CDCl 3 )δ8.07(d,J=8.3 Hz,1H),8.00(d,J=8.2 Hz,1H),7.85(s,1H),7.65(t,J=7.8 Hz,1H),7.57(t,J=7.5 Hz,1H),7.50(d,J=7.1 Hz,1H),7.41(t,J=7.6 Hz,1H),7.07(t,J=8.2 Hz,2H),6.69(d,J=8.5 Hz,1H),2.83(p,J=6.8 Hz,1H),1.34(d,J=6.9Hz,3H),1.24(d,J=6.9 Hz,3H).

[0215] 13 C NMR(100 MHz,CDCl 3)δ162.5,143.5,135.8,134.6,131.9,130.5,130.3,128.7,127.9,127.2,126.5,125.7,123.0,122.2,119.2,111.1,27.0,22.2,21.5.

[0216] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=7.1 min,t R (major)=8.8 min),ee=91%.

[0217] 16.

[0218] (S)-1-(naphthalene-1-yl)-2-propyl-1H-benzo[d]imidazole 4ab(45%yield,68%ee)White solid.Optical:[α] 25 D=-4.620°(c=0.11,CHCl 3 )

[0219] 1 H NMR(400 MHz,CDCl 3 )δ8.06(d,J=8.3 Hz,1H),8.00(d,J=8.2 Hz,1H),7.86(d,J=8.1Hz,1H),7.64(t,J=7.8 Hz,1H),7.56(t,J=7.3 Hz,1H),7.50(d,J=7.0 Hz,1H),7.41(t,J=7.6 Hz,1H),7.31-7.26(m,1H),7.18-7.09(m,2H),6.82(d,J=8.0 Hz,1H),2.68-2.55(m,2H),1.82-1.69(m,2H),0.87(t,J=7.4 Hz,3H).

[0220] 13 C NMR(100 MHz,CDCl 3)δ156.2,142.7,137.4,134.6,132.4,130.6,129.9,128.6,127.7,127.1,126.4,125.7,122.7,122.6,122.4,119.2,110.3,29.7,21.2,13.9.

[0221] HRMS(ESI):m / z calcd for C 20 H 18 N 2 [M+H]+:287.1543;found:287.1548

[0222] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=9.5 min,t R (major)=12.6 min),ee=68%.

[0223] 17.

[0224] (S)-5-fluoro-1-(naphthalene-1-yl)-2-propyl-1H-benzo[d]imidazole 4cb(88%yield,86%ee)White solid.

[0225] Optical:[α] 25 D=10.300°(c=0.40,CHCl 3 )

[0226] 1 H NMR(400 MHz,CDCl 3 )δ8.00(d,J=8.3 Hz,1H),7.94(d,J=8.3 Hz,1H),7.60-7.55(m,1H),7.50(t,J=7.9 Hz,1H),7.43(t,J=7.7 Hz,2H),7.36(t,J=7.7 Hz,1H),7.05(d,J=8.5Hz,1H),6.80(t,J=9.1 Hz,1H),6.65(dd,J=8.8,4.7 Hz,1H),2.51(m,2H),1.67(m,2H),0.79(t,J=7.4 Hz,3H).

[0227] 13C NMR(100 MHz,CDCl 3 )δ157.8,143.0,134.6,133.9,132.1,130.4,130.1,128.6,127.8,127.2,126.5,126.3,125.6,122.4,110.5(d, 3 J C-F =13 Hz),105.1(d, 2 J C-F =24 Hz),29.8,21.1,13.9.

[0228] HRMS(ESI):m / z calcd for C 20 H 17 FN 2 [M+H]+:305.1449;found:305.1444

[0229] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=8.7 min,t R (major)=10.9 min),ee=86%.

[0230] 18.

[0231] (S)-Methyl-5-(1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)pentanoate 4ae(78%yield,98%ee)White solid.

[0232] Optical:[α] 25 D=-5.500°(c=0.11,CHCl 3 )

[0233] 1 H NMR(400 MHz,CDCl 3)δ8.06(d,J=8.3 Hz,1H),8.01(d,J=8.3 Hz,1H),7.85(d,J=8.1Hz,1H),7.67-7.61(m,1H),7.57(t,J=7.6 Hz,1H),7.50(d,J=7.0 Hz,1H),7.42(t,J=7.6 Hz,1H),7.31-7.26(m,1H),7.13(t,J=9.3 Hz,2H),6.83(d,J=8.0 Hz,1H),3.58(s,3H),2.68-2.60(m,2H),2.23-2.19(m,2H),1.81-1.76(m,2H),1.62-1.55(m,2H).

[0234] 13 C NMR(100 MHz,CDCl 3 )δ173.8,155.7,142.6,137.3,134.6,132.2,130.5,130.0,128.6,127.8,127.1,126.3,125.7,122.7,122.5,122.4,119.2,110.3,51.5,33.7,27.4,27.1,24.5.HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=19.1 min,t R (major)=23.8 min),ee=98%.

[0235] 19.

[0236] (S)-Methyl-5-(5-methyl-1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)pentanoate 4be(96%yield,97%ee)Brown oil.

[0237] Optical:[α] 25 D=-4.620°(c=0.11,CHCl 3 )

[0238] 1 H NMR(400 MHz,CDCl 3)δ8.05(d,J=8.3 Hz,1H),8.00(d,J=8.2 Hz,1H),7.67-7.60(m,2H),7.56(t,J=7.5 Hz,1H),7.48(d,J=7.2 Hz,1H),7.44-7.38(m,1H),7.14(d,J=8.5 Hz,1H),6.95(d,J=8.2 Hz,1H),6.71(d,J=8.2 Hz,1H),3.58(s,3H),2.62(td,J=7.4,2.6 Hz,2H),2.49(s,3H),2.20(t,J=7.5 Hz,2H),1.77(p,J=7.7,7.3 Hz,2H),1.57(p,J=7.3 Hz,2H). 13 C NMR(100 MHz,CDCl 3 )δ173.8,155.6,142.9,135.5,134.6,132.4,132.1,130.5,129.9,128.6,127.7,127.1,126.3,125.7,124.1,122.5,119.1,109.8,51.5,33.7,27.4,27.2,24.5,21.6.HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=24.9 min,t R (major)=31.1 min),ee=97%.

[0239] 20.

[0240] (S)-Methyl-5-(5-fluoro-1-(naphthaleN-1-yl)-1H-benzo[d]imidazol-2-yl)pentanoate4ce(91%yield,98%ee)Brown oil.

[0241] Optical:[α] 25 D=-4.840°(c=0.11,CHCl 3 )

[0242] 1 H NMR(400 MHz,CDCl 3)δ8.08(d,J=8.3 Hz,1H),8.02(d,J=8.2 Hz,1H),7.69-7.62(m,1H),7.58(t,J=7.5 Hz,1H),7.54-7.47(m,2H),7.44(t,J=7.3 Hz,1H),7.11(d,J=8.4 Hz,1H),6.92-6.83(m,1H),6.74(dd,J=8.8,4.6 Hz,1H),3.58(s,3H),2.69-2.55(m,2H),2.21(t,J=7.5 Hz,2H),1.80(dd,J=15.2,7.2 Hz,2H),1.62-1.54(m,2H).

[0243] 13 C NMR(100 MHz,CDCl 3 )δ173.7,160.8,157.2,143.0(d, 3 J C-F =13 Hz),134.6,133.8,131.9,130.4,130.2,128.7,127.9,127.2,126.3,125.7,122.3,111.9(d, 2 J C-F =26Hz),110.6(d, 3 J C-F =10Hz),105.1(d, 2 J C-F =24 Hz),51.5,33.6,27.5,27.0,24.5.

[0244] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=17.1 min,t R (major)=20.8 min),ee=98%.

[0245] 21.

[0246] (S)-Methyl-5-(5-fluoro-1-(naphthaleN-1-yl)-1H-benzo[d]imidazol-2-yl)pentanoate4de(74%yield,98%ee)Brown oil.

[0247] Optical:[α] 25 D=-5.280°(c=0.12,CHCl 3 )

[0248] 1 H NMR(400 MHz,CDCl 3 )δ8.08(d,J=8.3 Hz,1H),8.01(d,J=8.3 Hz,1H),7.81(s,1H),7.65(t,J=7.7 Hz,1H),7.58(t,J=7.6 Hz,1H),7.49(d,J=7.2 Hz,1H),7.44(t,J=7.7 Hz,1H),7.09(d,J=8.4 Hz,2H),6.74(d,J=8.5 Hz,1H),3.58(s,3H),2.62(t,J=7.6 Hz,2H),2.21(t,J=7.4 Hz,2H),1.81-1.74(m,2H),1.57(q,J=7.5 Hz,2H).

[0249] 13 C NMR(100 MHz,CDCl 3 )δ173.7,157.1,143.5,135.9,134.6,131.7,130.3,128.7,128.1,128.0,127.3,126.3,125.7,123.2,122.2,119.1,111.1,51.6,33.6,27.4,27.0,24.5.

[0250] HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=24.0 min,t R (major)=29.1 min),ee=98%.

[0251] 22.

[0252] (S)-Methyl-5-(7-chloro-1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)pentanoate4fe(75%yield,83%ee)Brown solid.

[0253] Optical:[α] 25D=-3.600°(c=0.10,CHCl 3 )

[0254] 1 H NMR(400 MHz,CDCl 3 )δ8.07(d,J=8.2 Hz,1H),8.00(d,J=8.2 Hz,1H),7.79(d,J=7.6Hz,1H),7.65-7.60(m,1H),7.56(t,J=8.3 Hz,2H),7.44(t,J=7.6 Hz,1H),7.22(t,J=7.9 Hz,1H),7.15-7.06(m,2H),3.60(s,3H),2.56(td,J=7.5,4.3 Hz,2H),2.23(t,J=7.5 Hz,2H),1.82(p,J=7.0 Hz,2H),1.60(p,J=7.3 Hz,2H).

[0255] 13 C NMR(100 MHz,CDCl 3 )δ173.7,157.0,144.6,133.9,132.8,132.7,131.8,130.2,128.5,127.9,127.2,127.0,125.2,124.1,122.9,122.2,118.2,116.4,51.5,33.6,27.2,26.9,24.5.HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=35.1 min,t R (major)=40.6 min),ee=83%.

[0256] 23.

[0257] (S)-Methyl-5-(6-methoxy-1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)pentanoate4ge(82%yield,94%ee)Brown oil.

[0258] Optical:[α] 25 D=-5.040°(c=0.12,CHCl 3 )

[0259] 1 H NMR(400 MHz,CDCl 3 )δ8.08(d,J=8.3 Hz,1H),8.03(d,J=8.2 Hz,1H),7.74(d,J=8.8Hz,1H),7.67(t,J=7.8 Hz,1H),7.59(t,J=7.5 Hz,1H),7.52(d,J=7.1 Hz,1H),7.45(t,J=7.6 Hz,1H),7.20(d,J=8.5 Hz,1H),6.93(d,J=8.8 Hz,1H),6.32(s,1H),3.65(s,3H),3.59(s,3H),2.65-2.59(m,2H),2.22(t,J=7.5 Hz,2H),1.79(p,J=7.3Hz,2H),1.60(p,J=7.3 Hz,2H).

[0260] 13 C NMR(100 MHz,CDCl 3 )δ173.8,156.7,154.8,137.9,137.0,134.6,132.3,130.5,130.0,128.6,127.8,127.1,126.3,125.7,122.5,119.7,111.4,94.0,55.8,51.5,33.7,27.4,27.1,24.5.HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=34.7 min,t R (major)=44.1 min),ee=94%.

[0261] 24.

[0262] (S)-Ethyl-5-(1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)pentanoate4af(96%yield,97%ee)White solid.

[0263] Optical:[α] 25 D=-5.460°(c=0.13,CHCl 3 )

[0264] 1H NMR(400 MHz,CDCl 3 )δ8.06(d,J=8.3 Hz,1H),8.00(d,J=8.3 Hz,1H),7.85(d,J=8.1Hz,1H),7.67-7.61(m,1H),7.56(t,J=7.6 Hz,1H),7.50(d,J=6.3 Hz,1H),7.41(t,J=8.2 Hz,1H),7.31-7.25(m,1H),7.17-7.09(m,2H),6.83(d,J=8.0 Hz,1H),4.04(q,J=7.1 Hz,2H),2.70-2.58(m,2H),2.20(t,J=7.5 Hz,2H),1.84-1.76(m,2H),1.60-1.57(m,2H),1.18(t,J=7.1Hz,3H).

[0265] 13 C NMR(100 MHz,CDCl 3 )δ173.4,155.7,142.7,137.4,134.6,132.2,130.5,130.0,128.6,127.8,127.1,126.4,125.7,122.7,122.5,122.4,119.2,110.3,60.3,33.9,27.4,27.1,24.6,14.3.HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃;(t R (minor)=17.1 min,t R (major)=21.5 min),ee=97%.

[0266] 25.

[0267] (S)-Ethyl-5-(5-methyl-1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)pentanoate4bf(96%yield,97%ee)Brown oil.

[0268] Optical:[α] 25 D=-5.120°(c=0.10,CHCl 3 )

[0269] 1H NMR(400 MHz,CDCl 3 )δ8.05(d,J=8.3 Hz,1H),8.00(d,J=8.2 Hz,1H),7.67-7.60(m,2H),7.56(t,J=7.5 Hz,1H),7.49(d,J=17.6,1H)4,1H Hz,1H),7.15(d,J=8.5Hz,1H),6.95(d,J=8.1 Hz,1H),6.71(d,J=8.2 Hz,1H),4.03(q,J=7.1Hz,2H),2.62(t,J=7.7. Hz,2H),2.49(s,3H),2.18(t,J=7.5 Hz,2H),1.84-1.71(m,2H),1.57(p,J=7.4 Hz,2H),1.18(t,J=7.1 Hz,3H).

[0270] 13 C NMR(100 MHz,CDCl 3 )δ173.4,155.7,142.9,135.5,134.5,132.4,132.1,130.5,129.9,128.6,127.7,127. 1,126.3,125.7,124.1,122.5,119.1,109.8,60.3,33.9,27.4,27.2,24.6,21.6,14.2.

[0271] HRMS(ESI):m / z calcd for C 25 H 26 N 2 O 2 [M+H]+:387.2068;found:387.2064HPLCanalysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0 mL / min;λ=254nm;25℃ R (minor)=22.1 min,t R (major)=28.5 min),yes=97=.

[0272] 26 .

[0273] (S)-Ethyl-5-(5-fluoro-1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)pentanoate 4cf(95%yield,98%ee)Brown oil.

[0274] Optical:[α] 25 D=-5.280°(c=0.11,CHCl 3 )

[0275] 1 H NMR(400 MHz,CDCl 3 )δ8.07(d,J=8.3 Hz,1H),8.01(d,J=8.2 Hz,1H),7.68-7.61(m,1H),7.58(t,J=7.9 Hz,1H),7.55-7.47(m,2H),7.44(t,J=7.7 Hz,1H),7.11(d,J=8.4 Hz,1H),6.91-6.84(m,1H),6.73(dd,J=8.8,4.6 Hz,1H),4.04(q,J=7.1 Hz,2H),2.62(t,J=7.5Hz,2H),2.20(t,J=7.5 Hz,2H),1.86-1.73(m,2H),1.63-1.51(m,2H),1.19(t,J=7.1 Hz,3H). 13 C NMR(100 MHz,CDCl 3 )δ173.3,160.8,157.3,143.0(d, 3 J C-F =13Hz),134.6,133.8,131.9,130.4,130.2,128.7,127.9,127.2,126.3,125.7,122.2,111.9(d, 2 J C-F =26 Hz),110.6(d, 3 J C-F =10Hz),105.1(d, 2 J C-F =24 Hz),60.3,33.9,27.5,27.1,24.5,14.2.

[0276] HRMS(ESI):m / z calcd for C 24 H 23 FN 2 O 2[M+H]+:391.1817;found:391.1820HPLCanalysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0mL / min;λ=254nm;25℃;(t R (minor)=15.5min,t R (major)=19.0min),ee=98%.

[0277] 27.

[0278] (S)-Methyl-5-(1-(naphthalene-1-yl)-1H-benzo[d]imidazole-2-yl)hexanoate 4ag(78%yield,58%ee)White solid.

[0279] Optical:[α] 25 D=-4.400°(c=0.10,CHCl 3 )

[0280] 1 H NMR(400MHz,CDCl 3 )δ8.06(d,J=8.3Hz,1H),8.00(d,J=8.3Hz,1H),7.85(d,J=8.1Hz,1H),7.67-7.61(m,1H),7.56(t,J=7.5Hz,1H),7.50(d,J=7.2Hz,1H),7.41(t,J=8.1Hz,1H),7.28(t,J=8.1Hz,1H),7.17-7.09(m,2H),6.82(d,J=8.0Hz,1H),3.60(s,3H),2.63(m,2H),2.18(m,2H),1.75(m,2H),1.50(m,2H),1.31-1.25(m,2H).

[0281] 13 C NMR(100MHz,CDCl 3 )δ174.1,156.0,142.7,137.4,134.6,132.3,130.5,130.0,128.6,127.7,127.1,126.3,125.7,122.7,122.5,122.4,119.2,110.3,51.5,33.8,28.7,27.6,27.3,24.5.HRMS(ESI):m / z calcd for C24 H 24 N 2 O 2 [M+H]+:373.1911;found:373.1914HPLC analysis:Daicel Chiralpak AD-H;Hexane / iPrOH=90:10;flow:1.0mL / min;λ=254nm;25℃;(t R (minor)=18.1min,t R (major)=22.6min),ee=58%.

[0282] 28.

[0283] (S)-Methyl-5-(5-bromo-1-(naphthaleN-1-yl)-1H-benzo[d]imidazol-2-yl)pentanoate4ee(95%yield,95%ee)Brown oil.

[0284] Optical:[α] 25 D=-6.240°(c=0.12,CHCl 3 )

[0285] 1 H NMR(400MHz,CDCl 3 )δ8.08(d,J=8.3Hz,1H),8.02(d,J=8.3Hz,1H),7.98(s,1H),7.68-7.63(m,1H),7.61-7.56(m,1H),7.49(d,J=8.2Hz,1H),7.47-7.41(m,1H),7.23(d,J=6.7Hz,1H),7.08(d,J=8.2Hz,1H),6.72-6.68(m,1H),3.58(s,3H),2.66-2.58(m,2H),2.21(m,2H),1.79(m,7.0Hz,2H),1.58(m,2H).

[0286] 13 C NMR(100MHz,CDCl 3)δ172.6,155.8,142.9,135.2,133.5,130.6,129.2,129.2,127.6,126.9,126.2,125. 2,124.7,124.6,121.1,121.1,114.3,110.4,50.5,32.5,26.3,25.9,23.4,17.4.HPLC analysis:Daicel Chiralpak AD-H; Hexane / iPrOH=90:10; flow:1.0mL / min; λ=254nm; 25℃; (t R (minor)=28.1min,t R (major)=34.7min),ee=95%.

[0287] It should be noted that the specific parameters or some reagents in the above embodiments are specific embodiments or preferred embodiments of the present invention, rather than limiting the present invention; those skilled in the art can make adaptive adjustments within the scope of the present invention.

Claims

1. A method for preparing axially chiral N-benzoaryl imidazole based on a heterogeneous CPA (Chiral Phosphoric Acid) catalyst, characterized in that: Under the action of heterogeneous CPA catalyst, the diamine compound is mixed with a dicarbonyl compound and a solvent to undergo a cyclization reaction to obtain an axially chiral N-benzoaryl imidazole. The reaction equation is as follows: Wherein, R1 is -H, -CH3, halogen or -OMe; R2 is phenyl or pyridyl; R3 is -CH3, -COOCH3, CH(CH3)2 or -CH2CH2CH3; n is a positive integer from 1 to 2; X is -CH3 or -CH2CH3; Among them, the structural formula of the diamine compound is: The structural formula of dicarbonyl compounds is: The structural formula of axially chiral N-benzoarylimidazole is:

2. The method for preparing axially chiral N-benzoaryl imidazole based on heterogeneous CPA catalyst according to claim 1, characterized in that: The heterogeneous CPA catalyst is a PSCPA catalyst, and the structural formula of the PSCPA catalyst is as follows:

3. The method for preparing axially chiral N-benzoaryl imidazole based on heterogeneous CPA catalyst according to claim 1, characterized in that: The solvent includes at least one of ethyl acetate and toluene.

4. The method for preparing axially chiral N-benzoaryl imidazole based on heterogeneous CPA catalyst according to claim 1, characterized in that: The reaction temperature of the reaction is 40°C to 80°C.

5. The method for preparing axially chiral N-benzoaryl imidazole based on heterogeneous CPA catalyst according to claim 1, characterized in that: The amount of the heterogeneous CPA catalyst used is 2 mol% to 10 mol%.

6. The method for preparing axially chiral N-benzoaryl imidazole based on heterogeneous CPA catalyst according to claim 5, characterized in that: The amount of heterogeneous CPA catalyst used was 2 mol%.

7. The method for preparing axially chiral N-benzoaryl imidazole based on heterogeneous CPA catalyst according to claim 1, characterized in that: Diamine compounds include:

8. The method for preparing axially chiral N-benzoaryl imidazole based on heterogeneous CPA catalyst according to claim 1, characterized in that: The dicarbonyl compounds include:

9. The method for preparing axially chiral N-benzoaryl imidazole based on heterogeneous CPA catalyst according to claim 1, characterized in that: The molar ratio of the diamine compound to the dicarbonyl compound is 1:(1-3).

10. The method for preparing axially chiral N-benzoaryl imidazole based on heterogeneous CPA catalyst according to claim 1, characterized in that: The reaction is carried out under an inert gas atmosphere, wherein the inert gas is argon.